162 related articles for article (PubMed ID: 19482346)
1. Leukotriene E4: perspective on the forgotten mediator.
Lee TH; Woszczek G; Farooque SP
J Allergy Clin Immunol; 2009 Sep; 124(3):417-21. PubMed ID: 19482346
[TBL] [Abstract][Full Text] [Related]
2. The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications.
Austen KF; Maekawa A; Kanaoka Y; Boyce JA
J Allergy Clin Immunol; 2009 Sep; 124(3):406-14; quiz 415-6. PubMed ID: 19647860
[TBL] [Abstract][Full Text] [Related]
3. Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors.
Maekawa A; Kanaoka Y; Xing W; Austen KF
Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16695-700. PubMed ID: 18931305
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the human cysteinyl leukotriene 2 receptor.
Heise CE; O'Dowd BF; Figueroa DJ; Sawyer N; Nguyen T; Im DS; Stocco R; Bellefeuille JN; Abramovitz M; Cheng R; Williams DL; Zeng Z; Liu Q; Ma L; Clements MK; Coulombe N; Liu Y; Austin CP; George SR; O'Neill GP; Metters KM; Lynch KR; Evans JF
J Biol Chem; 2000 Sep; 275(39):30531-6. PubMed ID: 10851239
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene D
Liu T; Barrett NA; Nagai J; Lai J; Feng C; Boyce JA
J Allergy Clin Immunol; 2021 Jul; 148(1):195-208.e5. PubMed ID: 33285161
[TBL] [Abstract][Full Text] [Related]
6. Human T(H)2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1.
Parmentier CN; Fuerst E; McDonald J; Bowen H; Lee TH; Pease JE; Woszczek G; Cousins DJ
J Allergy Clin Immunol; 2012 Apr; 129(4):1136-42. PubMed ID: 22391114
[TBL] [Abstract][Full Text] [Related]
7. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.
Obase Y; Shimoda T; Tomari SY; Mitsuta K; Kawano T; Matsuse H; Kohno S
Chest; 2002 Jan; 121(1):143-50. PubMed ID: 11796443
[TBL] [Abstract][Full Text] [Related]
8. Differential signaling of cysteinyl leukotrienes and a novel cysteinyl leukotriene receptor 2 (CysLT₂) agonist, N-methyl-leukotriene C₄, in calcium reporter and β arrestin assays.
Yan D; Stocco R; Sawyer N; Nesheim ME; Abramovitz M; Funk CD
Mol Pharmacol; 2011 Feb; 79(2):270-8. PubMed ID: 21078884
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.
Walch L; Norel X; Bäck M; Gascard JP; Dahlén SE; Brink C
Br J Pharmacol; 2002 Dec; 137(8):1339-45. PubMed ID: 12466244
[TBL] [Abstract][Full Text] [Related]
10. An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea.
Bäck M; Kumlin M; Cotgreave IA; Dahlén SE
Br J Pharmacol; 2001 Aug; 133(7):1134-44. PubMed ID: 11487525
[TBL] [Abstract][Full Text] [Related]
11. Differential signaling defects associated with the M201V polymorphism in the cysteinyl leukotriene type 2 receptor.
Brochu-Bourque A; Véronneau S; Rola-Pleszczynski M; Stankova J
J Pharmacol Exp Ther; 2011 Feb; 336(2):431-9. PubMed ID: 20966037
[TBL] [Abstract][Full Text] [Related]
12. A functional study on CysLT(1) receptors in human eosinophils.
Ohshima N; Nagase H; Koshino T; Miyamasu M; Yamaguchi M; Hirai K; Yamamoto K; Fujisawa T; Nakagawa N; Kishikawa K; Morita Y
Int Arch Allergy Immunol; 2002 Sep; 129(1):67-75. PubMed ID: 12373000
[TBL] [Abstract][Full Text] [Related]
13. Leukotrienes, antileukotrienes and asthma.
Montuschi P
Mini Rev Med Chem; 2008 Jun; 8(7):647-56. PubMed ID: 18537720
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells.
Paruchuri S; Jiang Y; Feng C; Francis SA; Plutzky J; Boyce JA
J Biol Chem; 2008 Jun; 283(24):16477-87. PubMed ID: 18411276
[TBL] [Abstract][Full Text] [Related]
15. Expression of functional cysteinyl leukotriene receptors by human basophils.
Gauvreau GM; Plitt JR; Baatjes A; MacGlashan DW
J Allergy Clin Immunol; 2005 Jul; 116(1):80-7. PubMed ID: 15990778
[TBL] [Abstract][Full Text] [Related]
16. Hyperleukotrieneuria in patients with allergic and inflammatory disease.
Taniguchi M; Higashi N; Ono E; Mita H; Akiyama K
Allergol Int; 2008 Dec; 57(4):313-20. PubMed ID: 18946233
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene modifiers for asthma treatment.
Montuschi P; Peters-Golden ML
Clin Exp Allergy; 2010 Dec; 40(12):1732-41. PubMed ID: 21059119
[TBL] [Abstract][Full Text] [Related]
18. Effects of pranlukast, a cysteinyl leukotriene antagonist, on bronchial responsiveness to methacholine in aspirin-intolerant asthmatics treated with corticosteroids.
Ishioka S; Hozawa S; Haruta Y; Maeda A; Tamagawa K; Watanabe T; Hiyama K; Yamakido M
Hiroshima J Med Sci; 2000 Jun; 49(2):105-8. PubMed ID: 10920576
[TBL] [Abstract][Full Text] [Related]
19. Intratracheal administration of anaphylatoxin C5a potentiates antigen-induced pulmonary reactions through the prolonged production of cysteinyl-leukotrienes.
Kodani M; Sakata N; Takano Y; Kamiya H; Katsuragi T; Hugli TE; Abe M
Immunopharmacology; 2000 Sep; 49(3):263-74. PubMed ID: 10996024
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene D4 and interleukin-13 cooperate to increase the release of eotaxin-3 by airway epithelial cells.
Provost V; Langlois A; Chouinard F; Rola-Pleszczynski M; Chakir J; Flamand N; Laviolette M
PLoS One; 2012; 7(8):e43544. PubMed ID: 22952702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
